Does treatment with recombinant human erythropoietin affect the survival of anemic patients with cancer? Commentary

David P. Steensma, Thomas E. Witzig

Research output: Contribution to journalShort surveypeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)444-445
Number of pages2
JournalNature Clinical Practice Oncology
Issue number9
StatePublished - Sep 1 2005


  • Anemia
  • Cancer
  • Erythropoietin
  • Survival

ASJC Scopus subject areas

  • Oncology

Cite this